• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高级别浆液性输卵管卵巢癌中的三级淋巴结构:解剖部位至关重要。

Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters.

作者信息

Westbom-Fremer Sofia, Tran Lena, Ebbesson Anna, Martin de la Fuente Laura, Jönsson Jenny-Maria, Kannisto Päivi, Veerla Srinivas, Hedenfalk Ingrid

机构信息

Division of Oncology, Department of Clinical Sciences Lund, and Lund University Cancer Center, Lund University, Lund, Sweden.

Division of Obstetrics and Gynaecology, Department of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden.

出版信息

Cancer Immunol Immunother. 2025 Jan 3;74(2):56. doi: 10.1007/s00262-024-03911-2.

DOI:10.1007/s00262-024-03911-2
PMID:39751944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11699021/
Abstract

Tertiary lymphoid structures (TLS) in the tumor microenvironment are prognostically beneficial in many solid cancer types. Reports on TLS in high-grade serous tubo-ovarian carcinoma (HGSC) are few, and the prognostic impact is unclear. We investigated mature TLS (mTLS), immature TLS (iTLS) and lymphoid aggregates (LA) in primary adnexal tumors (PTs) and synchronous omental/peritoneal metastases (pMets) of HGSC. Whole H&E slides were scrutinized for mTLS and LA in a population-based cohort of 130 cases with stage III-IV HGSC. The immune cell tumor infiltration was evaluated with single chromogenic immunohistochemistry (IHC) on a tissue microarray (TMA) from the same cases. Selected whole slides (PT n = 11, pMet n = 10) of the cases most abundant in mTLS and LA were further investigated with multiplex IHC and immunofluorescence using digital image analysis (QuPath), to confirm TLS status and map the T and B lymphocyte subtypes. The results showed that mTLS were more common in pMets than in PTs but did not have an independent prognostic impact on overall or progression-free survival. The presence of mTLS correlated with intratumoral infiltration of CD8 cytotoxic T cells, FOXP3 regulatory T cells and PD-1 lymphocytes in pMets only. Although overall mTLS cell composition was similar between PTs and pMets, the outer zones of mTLS in PTs were more immune cell-rich. In conclusion, our results indicate differences in TLS presence and cellular elements between primary adnexal tumors and synchronous peritoneal metastases, which are important to consider when conducting studies of the immune environment in HGSC.

摘要

肿瘤微环境中的三级淋巴结构(TLS)在许多实体癌类型中具有预后益处。关于高级别浆液性输卵管卵巢癌(HGSC)中TLS的报道很少,其预后影响尚不清楚。我们研究了HGSC原发性附件肿瘤(PTs)和同步大网膜/腹膜转移灶(pMets)中的成熟TLS(mTLS)、未成熟TLS(iTLS)和淋巴样聚集物(LA)。在一个基于人群的130例III-IV期HGSC病例队列中,对全层苏木精-伊红(H&E)切片进行mTLS和LA的仔细检查。使用来自相同病例的组织微阵列(TMA)上的单显色免疫组织化学(IHC)评估免疫细胞肿瘤浸润情况。对mTLS和LA最丰富的病例的选定全层切片(PT n = 11,pMet n = 10),使用数字图像分析(QuPath)通过多重IHC和免疫荧光进一步研究,以确认TLS状态并绘制T和B淋巴细胞亚型图谱。结果显示,mTLS在pMets中比在PTs中更常见,但对总生存期或无进展生存期没有独立的预后影响。mTLS的存在仅与pMets中肿瘤内CD8细胞毒性T细胞、FOXP3调节性T细胞和PD-1淋巴细胞的浸润相关。尽管PTs和pMets之间mTLS的总体细胞组成相似,但PTs中mTLS的外层区域免疫细胞更丰富。总之,我们的结果表明原发性附件肿瘤和同步腹膜转移灶之间TLS的存在和细胞成分存在差异,这在进行HGSC免疫环境研究时是需要考虑的重要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/0f21fc25bd3f/262_2024_3911_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/e4be39651eb1/262_2024_3911_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/961a89a6fb60/262_2024_3911_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/026e4fe6da4f/262_2024_3911_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/0f21fc25bd3f/262_2024_3911_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/e4be39651eb1/262_2024_3911_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/961a89a6fb60/262_2024_3911_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/026e4fe6da4f/262_2024_3911_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ff/11699021/0f21fc25bd3f/262_2024_3911_Fig4_HTML.jpg

相似文献

1
Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters.高级别浆液性输卵管卵巢癌中的三级淋巴结构:解剖部位至关重要。
Cancer Immunol Immunother. 2025 Jan 3;74(2):56. doi: 10.1007/s00262-024-03911-2.
2
Immunotyping in tubo-ovarian high-grade serous carcinoma by PD-L1 and CD8+ T-lymphocytes predicts disease-free survival.PD-L1 和 CD8+ T 淋巴细胞在输卵管卵巢高级别浆液性癌中的免疫分型预测无病生存期。
APMIS. 2021 May;129(5):254-264. doi: 10.1111/apm.13116. Epub 2021 Feb 25.
3
The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions.高级别浆液性卵巢癌中三级淋巴结构的活性由部位、基质和细胞相互作用决定。
Cancer Cell. 2024 Nov 11;42(11):1864-1881.e5. doi: 10.1016/j.ccell.2024.09.007. Epub 2024 Oct 10.
4
Past failures and new horizons: the nuances of tertiary lymphoid structures in high-grade serous ovarian cancer may contribute to immunotherapy effectiveness.既往的失败与新的视野:高级别浆液性卵巢癌中三级淋巴结构的细微差别可能有助于免疫治疗的有效性。
J Immunother Cancer. 2025 Apr 17;13(4):e011670. doi: 10.1136/jitc-2025-011670.
5
PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Different Types of Tubo-ovarian Carcinoma and Their Prognostic Value in High-grade Serous Carcinoma.PD-L1 表达和 CD8+ 肿瘤浸润淋巴细胞在不同类型的输卵管卵巢癌中的表达及其在高级别浆液性癌中的预后价值。
Am J Surg Pathol. 2020 Aug;44(8):1050-1060. doi: 10.1097/PAS.0000000000001503.
6
Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer.肿瘤浸润浆细胞与三级淋巴结构、细胞毒性 T 细胞应答相关,并与卵巢癌的良好预后相关。
Clin Cancer Res. 2016 Jun 15;22(12):3005-15. doi: 10.1158/1078-0432.CCR-15-2762. Epub 2016 Jan 13.
7
Chemotherapy Drives Tertiary Lymphoid Structures That Correlate with ICI-Responsive TCF1+CD8+ T Cells in Metastatic Ovarian Cancer.化疗驱动三级淋巴结构,其与转移性卵巢癌中对免疫检查点抑制剂(ICI)有反应的TCF1 + CD8 + T细胞相关。
Clin Cancer Res. 2025 Jan 6;31(1):164-180. doi: 10.1158/1078-0432.CCR-24-1594.
8
Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer.治疗方案、手术结果和 T 细胞分化影响高等级浆液性卵巢癌中肿瘤浸润淋巴细胞的预后获益。
Clin Cancer Res. 2016 Feb 1;22(3):714-24. doi: 10.1158/1078-0432.CCR-15-1617. Epub 2015 Sep 18.
9
Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer.表达组织驻留记忆标志物 CD103 的肿瘤浸润淋巴细胞与高级别浆液性卵巢癌患者生存率的提高相关。
Clin Cancer Res. 2014 Jan 15;20(2):434-44. doi: 10.1158/1078-0432.CCR-13-1877. Epub 2013 Nov 4.
10
Exploring the impact of tertiary lymphoid structures maturity in NSCLC: insights from TLS scoring.探讨非小细胞肺癌中三级淋巴样结构成熟的影响:来自 TLS 评分的见解。
Front Immunol. 2024 Sep 20;15:1422206. doi: 10.3389/fimmu.2024.1422206. eCollection 2024.

引用本文的文献

1
Tertiary lymphoid structures: exploring opportunities to improve immunotherapy in ovarian cancer.三级淋巴结构:探索改善卵巢癌免疫治疗的机会
Front Immunol. 2025 May 22;16:1473969. doi: 10.3389/fimmu.2025.1473969. eCollection 2025.

本文引用的文献

1
Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer.三级淋巴结构和 B 细胞决定卵巢癌中具有临床相关性的 T 细胞表型。
Nat Commun. 2024 Mar 21;15(1):2528. doi: 10.1038/s41467-024-46873-w.
2
cGAS-STING pathway expression correlates with genomic instability and immune cell infiltration in breast cancer.cGAS-STING通路的表达与乳腺癌中的基因组不稳定和免疫细胞浸润相关。
NPJ Breast Cancer. 2024 Jan 2;10(1):1. doi: 10.1038/s41523-023-00609-z.
3
Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes.
高级浆液性卵巢癌肿瘤内空间和时间异质性:对手术和临床结局的影响。
Cell Rep Med. 2023 Jun 20;4(6):101055. doi: 10.1016/j.xcrm.2023.101055. Epub 2023 May 22.
4
Tertiary Lymphoid Structures Are Associated with a Favorable Prognosis in High-Grade Serous Ovarian Cancer Patients.三级淋巴结构与高级别浆液性卵巢癌患者的良好预后相关。
Reprod Sci. 2023 Aug;30(8):2468-2480. doi: 10.1007/s43032-023-01188-x. Epub 2023 Feb 9.
5
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.CCNE1 与输卵管-卵巢高级别浆液性癌患者的生存:卵巢肿瘤组织分析联盟研究。
Cancer. 2023 Mar 1;129(5):697-713. doi: 10.1002/cncr.34582. Epub 2022 Dec 26.
6
Ovarian cancer mutational processes drive site-specific immune evasion.卵巢癌突变过程驱动特定部位的免疫逃逸。
Nature. 2022 Dec;612(7941):778-786. doi: 10.1038/s41586-022-05496-1. Epub 2022 Dec 14.
7
Homologous Recombination Deficiency and Cyclin E1 Amplification Are Correlated with Immune Cell Infiltration and Survival in High-Grade Serous Ovarian Cancer.同源重组缺陷和细胞周期蛋白E1扩增与高级别浆液性卵巢癌中的免疫细胞浸润及生存相关。
Cancers (Basel). 2022 Dec 2;14(23):5965. doi: 10.3390/cancers14235965.
8
The tumor immune microenvironment in peritoneal carcinomatosis.腹膜肿瘤转移中的肿瘤免疫微环境。
Int Rev Cell Mol Biol. 2022;371:63-95. doi: 10.1016/bs.ircmb.2022.04.015. Epub 2022 Jun 27.
9
CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer.CXCL13 产生的 CD4+ T 细胞在卵巢癌三级淋巴结构的早期阶段积聚。
JCI Insight. 2022 Jun 22;7(12):e157215. doi: 10.1172/jci.insight.157215.
10
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome.B 细胞和三级淋巴结构作为肿瘤免疫微环境和临床结局的决定因素。
Nat Rev Clin Oncol. 2022 Jul;19(7):441-457. doi: 10.1038/s41571-022-00619-z. Epub 2022 Apr 1.